Cerus reported $-1.45M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Cerus USD -1.45M 488K Dec/2024
GRIFOLS EUR 329M 80M Jun/2026
Haemonetics USD 57.46M 5.12M Jun/2026
Neogen USD 3.1M 6.4M Mar/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -7.12M 1.38M Mar/2026
Quidel USD -15.3M 16.5M Jun/2026
Rockwell Medical USD 515K 1.84M Jun/2024
STAAR Surgical USD 10.1M 7.3M Jun/2026
Terumo JPY 89.48B 58.03B Jun/2026
Utah Medical Products USD 2.56M 124K Mar/2026